News | March 22, 2022
Barentz acquires life science ingredients, specialty chemicals distributor Divsa
Divsa's coverage across Central America bridges Barentz' leading positions in North and South America
Divsa's coverage across Central America bridges Barentz' leading positions in North and South America
Moving well beyond the traditional approach of testing a vaccine’s collective response in large populations, this precision approach can identify how an individual’s own immune system responds to a vaccine, offering an unprecedented opportunity to measure vaccine safety and effectiveness
It is a point-of-care portable, battery-operated, IoT-enabled platform with a sample to result in less than 1 hour
The Karnataka Health Promotion Trust held a day-long session in New Delhi to address health care challenges
The facility will enable research initiatives in analytical chemistry, biopharmaceuticals, and life sciences
CEPI will expand its partnership with icddr,b in Bangladesh, providing near to the additional US $ 1 million in funding to advance understanding of the Nipah virus
The investment will accelerate the overall Sarclisa development program
MTBVAC is a global public-private project that will be a milestone in the field of vaccinology
Aducanumab collaboration to convert from Eisai sharing of global profits and losses to a global royalty arrangement, effective January 1, 2023
Deploying solutions like Uniphore’s U-Self Serve and U-Assist with SpinSci’s Patient Engage and Patient Assist is an important step forward in creating frictionless patient experiences
Subscribe To Our Newsletter & Stay Updated
